Alicia McElhaney

Articles From This Author

Innoviva Says It Fends Off Sarissa Dissidents

By Alicia McElhaney

Apr 12, 2017 9:32 AM EDT

Mylan Falls on FDA Warning on Quality Control

By Alicia McElhaney

Apr 11, 2017 12:26 PM EDT

French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal

By Alicia McElhaney

Apr 11, 2017 9:30 AM EDT

Medivation Founder Takes Helm at Axovant, Shares Spike

By Alicia McElhaney

Apr 10, 2017 10:00 AM EDT

French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal

By Alicia McElhaney

Apr 7, 2017 9:25 AM EDT

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Apr 6, 2017 11:33 AM EDT

Innoviva Says It Fends Off Sarissa Dissidents

By Alicia McElhaney

Apr 6, 2017 10:32 AM EDT

Valeant Shares Dive on Reports of New Debt

By Alicia McElhaney

Apr 5, 2017 4:03 PM EDT

Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

By Alicia McElhaney

Apr 4, 2017 1:55 PM EDT

Immunomedics, Mylan Lead Biotech Movers

By Alicia McElhaney

Apr 3, 2017 10:10 AM EDT

The 'Dogs' of Wall Street: Here's a Look at Some of the Worst Performing Stocks of the Year

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Apr 2, 2017 5:40 PM EDT

Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals

By Alicia McElhaney

Mar 31, 2017 8:30 PM EDT

Ackman Reflects on His Valeant Investment

By Alicia McElhaney

Mar 30, 2017 8:30 PM EDT

Ackman Says Latest Investment Up 30% Since Fund Took Stake

By Alicia McElhaney

Mar 30, 2017 9:58 AM EDT

Mylan Falls on FDA Warning on Quality Control

By Alicia McElhaney

Mar 29, 2017 3:20 PM EDT

Here's Why Valeant's Stock Had Another Disastrous Week

By Alicia McElhaney

Mar 29, 2017 12:58 PM EDT

Despite Settling Decade-Long Suit, Mylan Shares Fall

By Alicia McElhaney

Mar 28, 2017 3:35 PM EDT

Former Valeant CEO Files Suit Against the Company

By Alicia McElhaney

Mar 28, 2017 9:12 AM EDT

Why the AHCA Has Already Failed

By Alicia McElhaney

Mar 27, 2017 2:30 PM EDT

Acorda Therapeutics Sinks on Invalidated Patents

By Alicia McElhaney

Mar 27, 2017 9:28 AM EDT

Immunomedics, Mylan Lead Biotech Movers

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Mar 24, 2017 11:41 AM EDT

Tenet Shares Drop as First Quarter Guidance Sinks

By Alicia McElhaney

Mar 24, 2017 10:27 AM EDT

Immunomedics, Mylan Lead Biotech Movers

By Alicia McElhaney

Mar 24, 2017 9:37 AM EDT

Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Mar 23, 2017 7:07 PM EDT

Valeant Shares Dive on Reports of New Debt

By Alicia McElhaney

Mar 23, 2017 10:49 AM EDT

Valeant's Downtrends Are Still Intact

By Alicia McElhaney

Mar 22, 2017 6:33 PM EDT

FTC Approves Abbott's Acquisition of Alere, Stock Jumps

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Mar 22, 2017 2:47 PM EDT

Acorda Therapeutics Sinks on Invalidated Patents

By Alicia McElhaney

Mar 22, 2017 9:31 AM EDT

Mylan's Government Connections Go Deeper Than Initially Reported

By Alicia McElhaney

Mar 21, 2017 9:06 AM EDT

Acorda Therapeutics Sinks on Invalidated Patents

By Alicia McElhaney

Mar 20, 2017 9:21 AM EDT

New Fred's Directors Seek To Send Message to FTC

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Mar 16, 2017 10:12 PM EDT

Here's Why Valeant's Stock Had Another Disastrous Week

By Alicia McElhaney

Mar 16, 2017 5:05 PM EDT

Insys Falls on Earnings Delay

By Alicia McElhaney

Mar 16, 2017 3:00 PM EDT

Health Care Investors Attempt to Parse Trump Budget

By Alicia McElhaney

Mar 16, 2017 10:25 AM EDT

Valeant's Downtrends Are Still Intact

By Alicia McElhaney

Mar 14, 2017 4:04 PM EDT

Shanda Goes Active on Community Health

By Alicia McElhaney

Mar 14, 2017 2:00 PM EDT

Here's Why Valeant's Stock Had Another Disastrous Week

By Alicia McElhaney

Mar 12, 2017 8:34 PM EDT

Incyte Pops on Continued Gilead Takeout Speculation

By Alicia McElhaney

Mar 10, 2017 4:30 PM EST

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

By Alicia McElhaney

Mar 9, 2017 1:33 PM EST

Valeant's Downtrends Are Still Intact

By Alicia McElhaney

Mar 9, 2017 12:17 PM EST

Sanofi Sues Mylan Over EpiPen Practices

By Alicia McElhaney

Mar 8, 2017 5:17 PM EST

Kraft Heinz Takes a Page From Weight Watchers, Inks Oprah for Product Line

By Alicia McElhaney

Mar 8, 2017 2:39 PM EST

Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

By Alicia McElhaney

Mar 7, 2017 10:23 AM EST

Valeant Shares Dive on Reports of New Debt

By Alicia McElhaney

Mar 6, 2017 4:26 PM EST

Mylan's Government Connections Go Deeper Than Initially Reported

CORPORATE GOVERNANCE

By Alicia McElhaney

Mar 3, 2017 6:07 PM EST

FDA Decision on Novartis Gene Therapy Drug Could Benefit Kite Pharma

MERGERS AND ACQUISITIONS

By Alicia McElhaney

Mar 2, 2017 2:00 PM EST

Mylan's Government Connections Go Deeper Than Initially Reported

By Alicia McElhaney

Mar 1, 2017 4:53 PM EST

Valeant Shares Dive on Reports of New Debt

By Alicia McElhaney

Feb 28, 2017 4:13 PM EST

Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals

By Alicia McElhaney

Feb 24, 2017 9:38 AM EST

Argos Plummets 72%, Leads Biotech Movers

RHHBY PDLI TRVN

By Alicia McElhaney

Feb 22, 2017 8:52 AM EST

CLOSE

CLOSE

CLOSE

CLOSE